Pioglitazone Tablet
Product Images NDC 0093-7271

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 0093-7271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical Structure (Image 1)
Chemical structure of Pioglitazone hydrochloride, depicting the molecular composition including aromatic rings, a thiazolidinedione moiety, and a hydrochloride component.*
FDA Label Image

Figure 1 (Image 2)

Figure 1 (Image 2)
A line graph showing the mean response over 26 weeks for Pioglitazone oral tablets at 15 mg, 30 mg, and 45 mg doses, compared to placebo. The X-axis represents time in weeks, and the Y-axis represents the mean value, with 15 mg, 30 mg, and 45 mg doses showing a downward trend compared to the placebo group's relatively stable mean.*
FDA Label Image

15 mg, 90s (Image 3)

15 mg, 90s (Image 3)
Pioglitazone Tablets USP 15 mg oral tablets label by Teva Pharmaceuticals USA, Inc. The label displays the NDC 0093-7271-56 and indicates a bottle containing 30 tablets. It includes directions for the pharmacist to dispense accompanying Medication Guide and specifies Rx only.*
FDA Label Image

30 mg, 90s (Image 4)

30 mg, 90s (Image 4)
Pioglitazone Tablets, USP 30 mg oral tablets label from Teva Pharmaceuticals USA, Inc. The label includes the NDC code 0093-7272-56 and indicates the package contains 30 tablets. It also advises pharmacists to dispense the accompanying medication guide to each patient.*
FDA Label Image

45 mg, 90s (Image 5)

45 mg, 90s (Image 5)
The label for Pioglitazone Tablets, USP shows a dosage strength of 45 mg in oral tablet form. The product is marketed by Teva Pharmaceuticals USA, Inc. The label includes a barcode, NDC code 0093-7273-56, and specifies a package size of 30 tablets. It also instructs pharmacists to dispense the accompanying medication guide to patients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.